ASND Quote, Trading Chart, Ascendis Pharma A/S
home / stock / asnd / asnd quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-04 | 152.63 | 143.45 | 154.45 | 140.45 | 576,589 |
| 2021-03-03 | 154.42 | 152.9 | 154.935 | 151.435 | 220,621 |
| 2021-03-02 | 156.53 | 155.13 | 156.715 | 151.98 | 141,940 |
| 2021-03-01 | 155.83 | 156.3 | 157.96 | 152.99 | 118,599 |
| 2021-02-26 | 158.48 | 154.97 | 159.2154 | 150.76 | 269,190 |
| 2021-02-25 | 153.09 | 158.66 | 159.74 | 152.11 | 310,673 |
| 2021-02-24 | 152.88 | 153.84 | 156.025 | 150.89 | 130,198 |
| 2021-02-23 | 153.43 | 152.89 | 154.99 | 150.81 | 122,199 |
| 2021-02-22 | 154.85 | 153.38 | 158.605 | 152.31 | 229,336 |
| 2021-02-19 | 159.96 | 158.56 | 162.6477 | 157.45 | 94,008 |
| 2021-02-18 | 166.96 | 158.49 | 166.96 | 158.49 | 258,457 |
| 2021-02-17 | 160.52 | 168.19 | 169 | 158.41 | 186,226 |
| 2021-02-16 | 161.97 | 160.65 | 163.98 | 159.135 | 261,457 |
| 2021-02-15 | 149.18 | 160.67 | 160.67 | 147.86 | 351,551 |
| 2021-02-12 | 149.18 | 160.67 | 160.67 | 147.86 | 350,214 |
| 2021-02-11 | 155 | 149.17 | 155 | 147.975 | 221,520 |
| 2021-02-10 | 154.6 | 154.13 | 156.72 | 151.36 | 180,805 |
| 2021-02-09 | 154.63 | 154.08 | 155.87 | 153.29 | 157,005 |
| 2021-02-08 | 153 | 153.93 | 156.77 | 152.21 | 183,665 |
| 2021-02-05 | 152.61 | 152.72 | 154.55 | 151.01 | 266,570 |
News, Short Squeeze, Breakout and More Instantly...
-
COPENHAGEN, Denmark, March 04, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, today announced that the company will hold a conf...
-
COPENHAGEN, Denmark, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced the launch of Outgrow GHD , a new online educational resource designe...
-
COPENHAGEN, Denmark, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, today announced that the company will participate ...